Research performed on ten DMD patients (receiving background therapy with GCs), compared to perfectly matched ten control male individuals showed attenuation of muscle ischemia and impaired functional sympatholysis by PDE5 inhibition [220]. This evidence concerns the gene PDE5A and Duchenne muscular dystrophy.